These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21448109)

  • 1. Weight gain induced with olanzapine in adolescent.
    Graovac M; Ružić K; Rebić J; Dadić-Hero E; Kaštelan A; Frančišković T
    Psychiatr Danub; 2011 Mar; 23(1):101-4. PubMed ID: 21448109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
    Cuerda C; Merchan-Naranjo J; Velasco C; Gutierrez A; Leiva M; de Castro MJ; Parellada M; Giráldez M; Bretón I; Camblor M; García-Peris P; Dulín E; Sanz I; Desco M; Arango C
    Clin Nutr; 2011 Oct; 30(5):616-23. PubMed ID: 21492975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of antipsychotic-induced weight gain during quetiapine treatment.
    Koponen H; Larmo I
    Int Clin Psychopharmacol; 2003 Nov; 18(6):355-6. PubMed ID: 14571156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The appearance of metabolic syndrome in treatment with atypical antipsychotics].
    Mosolov SN; Kabanov SO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):62-9. PubMed ID: 14681970
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia.
    Bushe C; Sniadecki J; Bradley AJ; Poole Hoffmann V
    J Psychopharmacol; 2010 Jul; 24(7):1001-9. PubMed ID: 19240085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
    Kryzhanovskaya LA; Xu W; Millen BA; Acharya N; Jen KY; Osuntokun O
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):157-65. PubMed ID: 22372514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Edema related to treatment with olanzapine].
    Wustmann T; Fiedler T; Gutmann P
    Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.